Pure Global

GMA-TulipTM, i-gelTM and the LMA-SupremeTM (LMA-S) Devices in Airway Management - Trial NCT06383494

Access comprehensive clinical trial information for NCT06383494 through Pure Global AI's free database. This phase not specified trial is sponsored by Zhejiang Cancer Hospital and is currently Recruiting. The study focuses on Anesthesia. Target enrollment is 276 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06383494
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06383494
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
GMA-TulipTM, i-gelTM and the LMA-SupremeTM (LMA-S) Devices in Airway Management
GMA-TulipTM, i-gelTM and the LMA-SupremeTM (LMA-S) Devices in Airway Management Under General Anesthesia, a Randomized Controlled Study

Study Focus

Anesthesia

LMA supreme group

Interventional

device

Sponsor & Location

Zhejiang Cancer Hospital

Hangzhou, China

Timeline & Enrollment

N/A

Apr 30, 2024

Dec 30, 2025

276 participants

Primary Outcome

Glottic exposure grading

Summary

Patients were randomly assigned to three extraglottic airway (EGA) devices groups for airway
 management after anesthesia induced. Fiberoptic bronchoscope (FB) guided glottic exposure
 grading was performed and other airway management quality was recorded.

ICD-10 Classifications

Anaesthetic, unspecified
Other and unspecified general anaesthetics
Local anaesthetics
Other complications of anaesthesia
Complication of anaesthesia during labour and delivery, unspecified

Data Source

ClinicalTrials.gov

NCT06383494

Device Trial